Laminin (laminin-1; alpha 1-beta 1-gamma 1) is known to promote myoblast proliferation, fusion, and myotube formation. Merosin (laminin-2 and -4; alpha 2-beta 1/beta 2-gamma 1) is the predominant laminin variant in skeletal muscle basement membranes; genetic defects affecting its structure or expression are the causes of some types of congenital muscular dystrophy. However, the precise nature of the functions of merosin in muscle remain unknown. We have developed an in vitro system that exploits human RD and mouse C2C12 myoblastic cell lines and their clonal variants to study the roles of merosin and laminin in myogenesis. In the parental cells, which fuse efficiently to multinucleated myotubes, merosin expression is upregulated as a function of differentiation while laminin expression is downregulated. Cells from fusion-deficient clones do not express either protein, but laminin or merosin added to the culture medium induced their fusion. Clonal variants which fuse, but form unstable myotubes, express laminin but not merosin. Exogenous merosin converted these myotubes to a stable phenotype, while laminin had no effect. Myotube instability was corrected most efficiently by transfection of the merosin-deficient cells with the merosin alpha 2 chain cDNA. Finally, merosin appears to promote myotube stability by preventing apoptosis. Hence, these studies identify novel biological functions for merosin in myoblast fusion and muscle cell survival; furthermore, these explain some of the pathogenic events observed in congenital muscular dystrophy caused by merosin deficiency and provide in vitro models to further investigate the molecular mechanisms of this disease.
Skip Nav Destination
Article navigation
15 September 1996
Article|
September 15 1996
Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival.
P H Vachon,
P H Vachon
Burnham Institute (La Jolla Cancer Research Center), California 92037, USA.
Search for other works by this author on:
F Loechel,
F Loechel
Burnham Institute (La Jolla Cancer Research Center), California 92037, USA.
Search for other works by this author on:
H Xu,
H Xu
Burnham Institute (La Jolla Cancer Research Center), California 92037, USA.
Search for other works by this author on:
U M Wewer,
U M Wewer
Burnham Institute (La Jolla Cancer Research Center), California 92037, USA.
Search for other works by this author on:
E Engvall
E Engvall
Burnham Institute (La Jolla Cancer Research Center), California 92037, USA.
Search for other works by this author on:
P H Vachon
Burnham Institute (La Jolla Cancer Research Center), California 92037, USA.
F Loechel
Burnham Institute (La Jolla Cancer Research Center), California 92037, USA.
H Xu
Burnham Institute (La Jolla Cancer Research Center), California 92037, USA.
U M Wewer
Burnham Institute (La Jolla Cancer Research Center), California 92037, USA.
E Engvall
Burnham Institute (La Jolla Cancer Research Center), California 92037, USA.
Online ISSN: 1540-8140
Print ISSN: 0021-9525
J Cell Biol (1996) 134 (6): 1483–1497.
Citation
P H Vachon, F Loechel, H Xu, U M Wewer, E Engvall; Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival.. J Cell Biol 15 September 1996; 134 (6): 1483–1497. doi: https://doi.org/10.1083/jcb.134.6.1483
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement